ReviewLife (Basel, Switzerland)2022

Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data.

Elisa Fiorentini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.